Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Ehrenstein V, Hellfritzsch M, Kahlert J, Langan SM, Urushihara H, Marinac-Dabic D, Lund JL, Sørensen HT, Benchimol EI. Validation of algorithms in studies based on routinely collected health data: general principles. Am J Epidemiol. 2024 Nov 4;193(11):1612-1624. doi: 10.1093/aje/kwae071. PubMed PMID: 38754870.
Lund JL, Matthews AA. Identifying target populations to align with decision-makers' needs. Am J Epidemiol. 2024 Nov 4;193(11):1503-1506. doi: 10.1093/aje/kwae129. PubMed PMID: 38897981; PubMed Central PMCID: PMC11538562.
Duchesneau ED, Reeder-Hayes K, Stürmer T, Kim DH, Edwards JK, Lund JL. Longitudinal trajectories of a claims-based frailty measure during adjuvant chemotherapy in women with stage I-III breast cancer. Oncologist. 2024 Oct 3;29(10):e1291-e1301. doi: 10.1093/oncolo/oyae092. PubMed PMID: 38716777; PubMed Central PMCID: PMC11449071.
Forster M, Deal AM, Page A, Vohra S, Wardell AC, Pak J, Lund JL, Nyrop KA, Muss HB. Dose delay, dose reduction, and early treatment discontinuation in Black and White women receiving chemotherapy for nonmetastatic breast cancer. Oncologist. 2024 Oct 3;29(10):e1246-e1259. doi: 10.1093/oncolo/oyae150. PubMed PMID: 38913986; PubMed Central PMCID: PMC11449010.
Baggett CD, Jackson BE, Green L, Kuo TM, Kim K, Zhou X, Reeder-Hayes KE, Lund JL, Wheeler SB, Olshan AF. Cancer information and population health resource: a resource for catchment area data and cancer outcomes research. JNCI Cancer Spectr. 2024 Sep 2;8(5). doi: 10.1093/jncics/pkae069. PubMed PMID: 39141446; PubMed Central PMCID: PMC11410194.
Duchesneau ED, Kim DH, Stürmer T, Reeder-Hayes K, Edwards JK, Faurot KR, Lund JL. Longitudinal Changes in a Claims-Based Frailty Proxy Measure Compared to Concurrent Changes in the Fried Frailty Phenotype. J Gerontol A Biol Sci Med Sci. 2024 Sep 1;79(9). doi: 10.1093/gerona/glae174. PubMed PMID: 38995106; PubMed Central PMCID: PMC11333825.
Latour CD, Delgado M, Su IH, Wiener C, Acheampong CO, Poole C, Edwards JK, Quinto K, Stürmer T, Lund JL, Li J, Lopez N, Concato J, Funk MJ. Use of Sensitivity Analyses to Assess Uncontrolled Confounding from Unmeasured Variables in Observational, Active Comparator Pharmacoepidemiologic Studies: A Systematic Review. Am J Epidemiol. 2024 Aug 3;. doi: 10.1093/aje/kwae234. [Epub ahead of print] PubMed PMID: 39098826.
Niznik JD, Lund JL, Hanson LC, Colón-Emeric C, Kelley CJ, Gilliam M, Thorpe CT. A comparison of dementia diagnoses and cognitive function measures in Medicare claims and the Minimum Data Set. J Am Geriatr Soc. 2024 Aug;72(8):2381-2390. doi: 10.1111/jgs.19019. Epub 2024 May 30. PubMed PMID: 38814274; PubMed Central PMCID: PMC11323171.
Howlader N, Lund JL, Enewold L, Stevens J, McNeel T, Rivera D, Mariotto A, Cronin KA. Real-world lessons: combining cancer registry and retail pharmacy data for oral cancer drugs. J Natl Cancer Inst Monogr. 2024 Aug 1;2024(65):162-167. doi: 10.1093/jncimonographs/lgae023. PubMed PMID: 39102884; PubMed Central PMCID: PMC11300020.
Lund JL, Rivera MP, Su IH, Long JM, Chen X, Pak J, Hudgens MG, Stürmer T, Reuland DS, Henderson LM. Estimating the Effects of Cancer Screening in Clinical Practice Settings: The Role of Selective Uptake and Suboptimal Adherence along the Cancer Screening Continuum. Cancer Epidemiol Biomarkers Prev. 2024 Aug 1;33(8):984-988. doi: 10.1158/1055-9965.EPI-23-1491. PubMed PMID: 39012954; PubMed Central PMCID: PMC11351907.
Richardson DR, Zhou X, Reeder-Hayes K, Jensen CE, Islam J, Loh KP, Gupta A, Basch E, Bennett AV, Bridges JFP, Wheeler SB, Wood WA, Baggett CD, Lund JL. Home Time Among Older Adults With Acute Myeloid Leukemia Following Chemotherapy. JAMA Oncol. 2024 Aug 1;10(8):1038-1046. doi: 10.1001/jamaoncol.2024.1823. PubMed PMID: 38869885; PubMed Central PMCID: PMC11177219.
Metwally EM, Lund JL, Drummond MB, Peacock Hinton S, Poole C, Thompson CA. COPD With Lung Cancer Among Older United States Adults: Prevalence, Diagnostic Timeliness, and Association With Earlier Stage Tumors. Chronic Obstr Pulm Dis. 2024 Jul 25;11(4):382-385. doi: 10.15326/jcopdf.2024.0489. PubMed PMID: 38838253; PubMed Central PMCID: PMC11363966.
Thai ST, Lund JL, Poole C, Buse JB, Stürmer T, Harmon CA, Al-Obaidi M, Williams GR. Skeletal muscle density performance for screening frailty in older adults with cancer and the impact of diabetes: The CARE Registry. J Geriatr Oncol. 2024 Jul;15(6):101815. doi: 10.1016/j.jgo.2024.101815. Epub 2024 Jun 18. PubMed PMID: 38896951; PubMed Central PMCID: PMC11346769.
Mitchell AP, Kinlaw AC, Peacock-Hinton S, Dusetzina SB, Winn AN, Sanoff HK, Lund JL. Commercial Versus Medicaid Insurance and Use of High-Priced Anticancer Treatments. Oncologist. 2024 Jun 3;29(6):527-533. doi: 10.1093/oncolo/oyae035. PubMed PMID: 38484395; PubMed Central PMCID: PMC11144993.
Duchesneau ED, Stürmer T, Kim DH, Reeder-Hayes K, Edwards JK, Faurot KR, Lund JL. Performance of a Claims-Based Frailty Proxy Using Varying Frailty Ascertainment Lookback Windows. Med Care. 2024 May 1;62(5):305-313. doi: 10.1097/MLR.0000000000001994. Epub 2024 Mar 12. PubMed PMID: 38498870; PubMed Central PMCID: PMC10997449.
Lund JL, Cacciatore J, Tylock R, Su IH, Sharma S, Hinton SP, Smith S, Nowels MA, Chen X, Duberstein PR, Hanson LC, Mohile SG. Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials. JCO Clin Cancer Inform. 2024 Apr;8:e2300183. doi: 10.1200/CCI.23.00183. PubMed PMID: 38564692; PubMed Central PMCID: PMC11000769.
Niznik JD, Shmuel S, Pate V, Thorpe CT, Hanson LC, Rice C, Lund JL. Validating claims-based definitions for deprescribing: Bridging the gap between clinical and administrative data. Pharmacoepidemiol Drug Saf. 2024 Apr;33(4):e5784. doi: 10.1002/pds.5784. PubMed PMID: 38556843; PubMed Central PMCID: PMC11145562.
Henderson LM, Su IH, Rivera MP, Pak J, Chen X, Reuland DS, Lund JL. Prevalence of Lung Cancer Screening in the US, 2022. JAMA Netw Open. 2024 Mar 4;7(3):e243190. doi: 10.1001/jamanetworkopen.2024.3190. PubMed PMID: 38512257; PubMed Central PMCID: PMC10958241.
Duchesneau ED, Shmuel S, Faurot KR, Park J, Musty A, Pate V, Kinlaw AC, Stürmer T, Yang YC, Funk MJ, Lund JL. Translation of a Claims-Based Frailty Index From the International Classification of Diseases, Ninth Revision, Clinical Modification to the Tenth Revision. Am J Epidemiol. 2023 Nov 10;192(12):2085-2093. doi: 10.1093/aje/kwad151. PubMed PMID: 37431778; PubMed Central PMCID: PMC10988220.
Duchesneau ED, McNeill AM, Schary W, Pate V, Lund JL. Prognosis of older adults with chronic lymphocytic leukemia: A Surveillance, Epidemiology, and End Results-Medicare cohort study. J Geriatr Oncol. 2023 Nov;14(8):101602. doi: 10.1016/j.jgo.2023.101602. Epub 2023 Sep 9. PubMed PMID: 37696241.
Niznik J, Colón-Emeric C, Thorpe CT, Kelley CJ, Gilliam M, Lund JL, Hanson LC. Prescriber Perspectives and Experiences with Deprescribing Versus Continuing Bisphosphonates in Older Nursing Home Residents with Dementia. J Gen Intern Med. 2023 Nov;38(15):3372-3380. doi: 10.1007/s11606-023-08275-4. Epub 2023 Jun 27. PubMed PMID: 37369891; PubMed Central PMCID: PMC10682438.
Lund JL, Lo Re V 3rd. Pharmacoepidemiology and Drug Safety's core concepts in pharmacoepidemiology section at 1 year: Where do we go from here?. Pharmacoepidemiol Drug Saf. 2023 Nov;32(11):1315-1316. doi: 10.1002/pds.5646. Epub 2023 Jun 1. PubMed PMID: 37263775.
Lee S, Bennett AV, Zhou X, Betof Warner A, Trogdon JG, Kent EE, Lund JL. Real-world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy. Pharmacoepidemiol Drug Saf. 2023 Sep;32(9):988-1000. doi: 10.1002/pds.5630. Epub 2023 Apr 24. PubMed PMID: 37095605.
Yang JY, Lund JL, Funk MJ, Hudgens MG, Lewis JD, Kappelman MD. Utilization of Treat-to-Target Monitoring Colonoscopy After Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease. Am J Gastroenterol. 2023 Sep 1;118(9):1638-1647. doi: 10.14309/ajg.0000000000002294. Epub 2023 Apr 13. PubMed PMID: 37053548.
Anderson C, Peery AF, Bae-Jump VL, Brewster WR, Lund JL, Olshan AF, Nichols HB. Gastrointestinal outcomes among older women with endometrial cancer. Gynecol Oncol. 2023 Aug;175:114-120. doi: 10.1016/j.ygyno.2023.06.009. Epub 2023 Jun 22. PubMed PMID: 37354788.
Su IH, Lund JL, Gaber CE, Sanoff HK, Strassle PD, Duchesneau ED. Regarding "Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs". Oncologist. 2023 Jul 5;28(7):e588-e589. doi: 10.1093/oncolo/oyad130. PubMed PMID: 37210593; PubMed Central PMCID: PMC10322127.
Duchesneau ED, Shmuel S, Faurot KR, Musty A, Park J, Stürmer T, Kinlaw AC, Yang YC, Lund JL. Missing data approaches in longitudinal studies of aging: A case example using the National Health and Aging Trends Study. PLoS One. 2023;18(6):e0286984. doi: 10.1371/journal.pone.0286984. eCollection 2023. PubMed PMID: 37289795; PubMed Central PMCID: PMC10249888.
Hsu CD, Henderson LM, Jackson BE, Baggett CD, Funk MJ, Olshan AF, Gupta P, Barritt AS, Sanoff HK, Wheeler SB, Moon AM, Lund JL. Hepatocellular Carcinoma Surveillance among Individuals with Cirrhosis: Trends by Payer, Etiology, and Calendar Year, from a Statewide, Multi-Payer Dataset, 2010-2018. Cancer Epidemiol Biomarkers Prev. 2023 May 24;:OF1-OF10. doi: 10.1158/1055-9965.EPI-22-1358. [Epub ahead of print] PubMed PMID: 37222672.
Gaber CE, Edwards JK, Lund JL, Peery AF, Richardson DB, Kinlaw AC. Inverse Probability Weighting to Estimate Exposure Effects on the Burden of Recurrent Outcomes in the Presence of Competing Events. Am J Epidemiol. 2023 May 5;192(5):830-839. doi: 10.1093/aje/kwad031. PubMed PMID: 36790815; PubMed Central PMCID: PMC10423633.
Yang JY, Lund JL, Pate V, Kappelman MD. Utilization of Colonoscopy Following Treatment Initiation in U.S. Commercially Insured Patients With Inflammatory Bowel Disease, 2013-2019. Inflamm Bowel Dis. 2023 May 2;29(5):735-743. doi: 10.1093/ibd/izac136. PubMed PMID: 35929644; PubMed Central PMCID: PMC10152285.
D'Arcy ME, Stürmer T, Sandler RS, Baron JA, Jonsson-Funk ML, Troester MA, Lund JL. Healthcare system engagement and algorithm-identified cancer incidence following initiation of a new medication. Pharmacoepidemiol Drug Saf. 2023 Mar;32(3):321-329. doi: 10.1002/pds.5556. Epub 2022 Nov 30. PubMed PMID: 36394182; PubMed Central PMCID: PMC9931672.
Park J, Kent EE, Lund JL, Anderson C, Olshan AF, Brewster WR, Nichols HB. Adjuvant radiation therapy and health-related quality of life among older women with early-stage endometrial cancer: an analysis using the SEER-MHOS linkage. Cancer Causes Control. 2023 Mar;34(3):223-231. doi: 10.1007/s10552-022-01658-8. Epub 2022 Dec 2. PubMed PMID: 36459312.
Shmuel S, Leonard CE, Bykov K, Filion KB, Seamans MJ, Lund JL. Breaking Research Silos and Stimulating "Innovation at the Edges" in Epidemiology. Am J Epidemiol. 2023 Feb 24;192(3):323-327. doi: 10.1093/aje/kwac192. PubMed PMID: 36326539; PubMed Central PMCID: PMC10372858.
Fix J, Vielot NA, Lund JL, Weber DJ, Smith JS, Hudgens MG, Becker-Dreps S. Patterns of use of recombinant zoster vaccine among commercially-insured immunocompetent and immunocompromised adults 50-64 years old in the United States. Vaccine. 2023 Jan 4;41(1):49-60. doi: 10.1016/j.vaccine.2022.10.076. Epub 2022 Nov 14. PubMed PMID: 36396511.
Park J, Lund JL, Kent EE, Anderson C, Brewster WR, Olshan AF, Nichols HB. Patient characteristics and health system factors associated with adjuvant radiation therapy receipt in older women with early-stage endometrial cancer. J Geriatr Oncol. 2023 Jan;14(1):101371. doi: 10.1016/j.jgo.2022.08.020. Epub 2022 Sep 8. PubMed PMID: 36088216.
Pak J, Lund JL, Keil A, Westreich D, Stürmer T, Wohl D, Farel C, Drummond MB, Webster-Clark M. A systematic review of whether COVID-19 randomized controlled trials reported on demographic and clinical characteristics. Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1219-1227. doi: 10.1002/pds.5533. Epub 2022 Oct 5. Review. PubMed PMID: 35996832; PubMed Central PMCID: PMC9538362.
Niznik JD, Gilliam MA, Colón-Emeric C, Thorpe CT, Lund JL, Berry SD, Hanson LC. Controversies in Osteoporosis Treatment of Nursing Home Residents. J Am Med Dir Assoc. 2022 Dec;23(12):1928-1934. doi: 10.1016/j.jamda.2022.09.013. Epub 2022 Nov 3. Review. PubMed PMID: 36335990; PubMed Central PMCID: PMC9885478.
Duchesneau ED, Jackson BE, Webster-Clark M, Lund JL, Reeder-Hayes KE, Nápoles AM, Strassle PD. The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example. Cancer Epidemiol Biomarkers Prev. 2022 Nov 2;31(11):2079-2086. doi: 10.1158/1055-9965.EPI-22-0495. PubMed PMID: 35984990; PubMed Central PMCID: PMC9627261.
Sarri G, Bennett D, Debray T, Deruaz-Luyet A, Soriano Gabarró M, Largent JA, Li X, Liu W, Lund JL, Moga DC, Gokhale M, Rentsch CT, Wen X, Yanover C, Ye Y, Yun H, Zullo AR, Lin KJ. ISPE-Endorsed Guidance in Using Electronic Health Records for Comparative Effectiveness Research in COVID-19: Opportunities and Trade-Offs. Clin Pharmacol Ther. 2022 Nov;112(5):990-999. doi: 10.1002/cpt.2560. Epub 2022 Mar 11. PubMed PMID: 35170021; PubMed Central PMCID: PMC9087010.
Gaber CE, Shaheen NJ, Edwards JK, Sandler RS, Nichols HB, Sanoff HK, Lund JL. Trimodality Therapy vs Definitive Chemoradiation in Older Adults With Locally Advanced Esophageal Cancer. JNCI Cancer Spectr. 2022 Nov 1;6(6). doi: 10.1093/jncics/pkac069. PubMed PMID: 36205723; PubMed Central PMCID: PMC9623425.
Gaber CE, Shaheen NJ, Sandler RS, Edwards JK, Nichols HB, Sanoff HK, Lund JL. Patterns of care amongst older adults diagnosed with locally advanced esophageal cancer: A cohort study. J Geriatr Oncol. 2022 Nov;13(8):1178-1187. doi: 10.1016/j.jgo.2022.08.009. Epub 2022 Aug 23. PubMed PMID: 36008272.
Webster-Clark M, Keil AP, Robert N, Frytak JR, Boyd M, Stürmer T, Sanoff H, Westreich D, Lund JL. Comparing Trial and Real-world Adjuvant Oxaliplatin Delivery in Patients With Stage III Colon Cancer Using a Longitudinal Cumulative Dose. JAMA Oncol. 2022 Oct 13;8(12):1821-4. doi: 10.1001/jamaoncol.2022.4445. [Epub ahead of print] PubMed PMID: 36227604; PubMed Central PMCID: PMC9562097.
Anderson C, Olshan AF, Bae-Jump VL, Brewster WR, Lund JL, Nichols HB. Cardiovascular disease diagnoses among older women with endometrial cancer. Gynecol Oncol. 2022 Oct;167(1):51-57. doi: 10.1016/j.ygyno.2022.08.014. Epub 2022 Aug 22. PubMed PMID: 36008183.
Chubak J, Lund JL. Noncancer comparators in cancer survivorship studies. Cancer. 2022 Aug 1;128(15):2994. doi: 10.1002/cncr.34253. Epub 2022 May 3. PubMed PMID: 35503856.
Gaber CE, Cotton CC, Eluri S, Lund JL, Farrell TM, Dellon ES. Autoimmune and viral risk factors are associated with achalasia: A case-control study. Neurogastroenterol Motil. 2022 Jul;34(7):e14312. doi: 10.1111/nmo.14312. Epub 2021 Dec 26. PubMed PMID: 34957646; PubMed Central PMCID: PMC9232907.
Anderson C, Olshan AF, Park J, Bae-Jump VL, Brewster WR, Lund JL, Nichols HB. Adverse Urinary System Diagnoses among Older Women with Endometrial Cancer. Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1368-1375. doi: 10.1158/1055-9965.EPI-22-0236. PubMed PMID: 35545287.
Anderson C, Lund JL, Park J, Brewster W, Bae-Jump V, Olshan AF, Nichols HB. Adverse Urinary System Outcomes among Older Women with Endometrial Cancer. Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1508. doi: 10.1158/1055-9965.EPI-22-0467. PubMed PMID: 35775217.
Hsu CD, Nichols HB, Lund JL. Polypharmacy and medication use by cancer history in a nationally representative group of adults in the USA, 2003-2014. J Cancer Surviv. 2022 Jun;16(3):659-666. doi: 10.1007/s11764-021-01059-x. Epub 2021 May 25. PubMed PMID: 34032998.
Penberthy LT, Rivera DR, Lund JL, Bruno MA, Meyer AM. An overview of real-world data sources for oncology and considerations for research. CA Cancer J Clin. 2022 May;72(3):287-300. doi: 10.3322/caac.21714. Epub 2021 Dec 29. Review. PubMed PMID: 34964981.
Hicks BM, Chun DS, Peacock Hinton S, Hsu CD, Tan HJ, Lund JL. Patterns of first-line targeted therapy utilization and adherence among older adults diagnosed with metastatic renal cell carcinoma. J Geriatr Oncol. 2022 Apr;13(3):325-333. doi: 10.1016/j.jgo.2021.11.006. Epub 2021 Nov 12. PubMed PMID: 34782282.
What would you like to do?